Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Location

MS status

Recruitment Status

Phase

Drugs

Prior Immunotherapy Allowed

NCT ID

Title key word search

Date Trial Added

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Phase	Date Added	Location	Prior IO Allowed	CRC-directed	Status	Drugs	Tags
NCT ID NCT03475004	TitleStudy of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer	Phase Phase 2	Date Added 2018-03-23	Location Colorado, United States	Prior IO Allowed No	CRC-directed Yes	Status Active, not recruiting	Drugs Pembrolizumab, Bevacizumab, and Binimetinib	Tags MSS/ MMRp
NCT ID NCT03626922	TitleStudy of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients	Phase Phase 1	Date Added 2018-08-13	Location Florida, United States Illinois, United States Michigan, United States Minnesota, United States Pennsylvania, United States	Prior IO Allowed No	CRC-directed Yes	Status Active, not recruiting	Drugs Dexamethasone, oxaliplatin, Pembrolizumab, Pemetrexed, Alimta, Eloxatin, Keytruda	Tags MSS/ MMRp
NCT ID NCT04991948	TitleStudy of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer	Phase Phase 1	Date Added 2021-08-05	Location Florida, United States Belgium	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs CYAD-101, FOLFOX, Pembrolizumab	Tags MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05239741	TitleStudy of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)	Phase Phase 3	Date Added 2022-02-15	Location China	Prior IO Allowed No	CRC-directed Yes	Status Recruiting	Drugs 5-Fluorouracil, Irinotecan, Leucovorin, oxaliplatin	Tags MSI-H/ MMRd
NCT ID NCT02608385	TitleStudy of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors	Phase Phase 1	Date Added 2015-11-18	Location Illinois, United States	Prior IO Allowed Yes	CRC-directed No	Status Active, not recruiting	Drugs Pembrolizumab	Tags MSS/ MMRp
NCT ID NCT06106308	TitleStudy of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation	Phase Phase 2	Date Added 2023-10-30	Location Arizona, United States Arkansas, United States California, United States Florida, United States Hawaii, United States Indiana, United States Kansas, United States Michigan, United States Minnesota, United States Missouri, United States Nevada, United States New York, United States Ohio, United States Oregon, United States Pennsylvania, United States Tennessee, United States Texas, United States Utah, United States Virginia, United States Washington, United States Wisconsin, United States	Prior IO Allowed No	CRC-directed Yes	Status Active, not recruiting	Drugs Bevacizumab, FOLFIRI, FOLFOX, Onvansertib	Tags MSS/ MMRp
NCT ID NCT03155061	TitleStudy of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors	Phase Phase 1	Date Added 2017-05-16	Location Japan	Prior IO Allowed Yes	CRC-directed No	Status Active, not recruiting	Drugs ONO-4538, ONO-4578, Opdivo	Tags MSS/ MMRp
NCT ID NCT05215574	TitleStudy of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors	Phase Phase 1	Date Added 2022-01-31	Location Arizona, United States California, United States Florida, United States Michigan, United States New York, United States Oklahoma, United States Texas, United States	Prior IO Allowed Yes	CRC-directed Yes	Status Active, not recruiting	Drugs NGM831, NGM831 plus pembrolizumab	Tags MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03476681	TitleStudy of NEO-201 in Solid Tumors Expansion Cohorts	Phase Phase 1, Phase 2	Date Added 2018-03-26	Location Maryland, United States Virginia, United States	Prior IO Allowed Yes	CRC-directed No	Status Recruiting	Drugs NEO-201 in combination with pembrolizumab	Tags MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06034860	TitleStudy of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types	Phase Phase 1	Date Added 2023-09-13	Location California, United States Indiana, United States Missouri, United States New York, United States Virginia, United States	Prior IO Allowed Yes	CRC-directed No	Status Active, not recruiting	Drugs MT-8421, Nivolumab, Opdivo	Tags MSI-H/ MMRd

Showing 41 to 50 of 299 entries